Neuphoria Therapeutics Inc.
Neuphoria Therapeutics Inc. (NEUP) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Neuphoria Therapeutics Inc. (NEUP) stock price today?
As of Dec 16, 2025, 9:00 PM UTC, Neuphoria Therapeutics Inc. (NEUP) stock is trading at $3.90. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date NEUP stock quotes for informed trading decisions.
What is Neuphoria Therapeutics Inc.'s market capitalization?
Neuphoria Therapeutics Inc. (NEUP) has a market capitalization of approximately $7.3M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Neuphoria Therapeutics Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the NEUP stock price changes.
What is the 52-week range for Neuphoria Therapeutics Inc. stock?
Neuphoria Therapeutics Inc. (NEUP) stock has traded in a 52-week range of $2.77 — $21.40. The 52-week range shows the highest and lowest prices at which NEUP traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Neuphoria Therapeutics Inc. stock price to this range provides context for recent price action.
How much trading volume does Neuphoria Therapeutics Inc. stock have?
Neuphoria Therapeutics Inc. (NEUP) stock recently traded approximately 41.1K shares. Trading volume indicates market liquidity and investor interest in NEUP. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Neuphoria Therapeutics Inc. stock.
Does Neuphoria Therapeutics Inc. pay dividends to shareholders?
Yes, Neuphoria Therapeutics Inc. (NEUP) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Neuphoria Therapeutics Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.
What is Neuphoria Therapeutics Inc.'s intraday price range?
Today, Neuphoria Therapeutics Inc. (NEUP) stock has traded in a range of $3.84 — $4.03. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring NEUP's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.
Where does AlphaPilot get Neuphoria Therapeutics Inc. stock data?
AlphaPilot sources real-time NEUP stock quotes, fundamental financial data, and historical price charts for Neuphoria Therapeutics Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Neuphoria Therapeutics Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of NEUP stock performance.